FDA Approves Biogen Idec's ELOCATE™, First Long Lasting Hemophilia A Therapy

– Only Hemophilia A Therapy to Provide Bleeding Protection with Prophylactic Infusions Every Three to Five Days –– Approval of Biogen Idec’s Second Innovative Hemophilia Therapy with Prolonged Circulation This Year –Biogen Idec (NASDAQ: BIIB) announced that the U.S. Food and Drug Administration (FDA) has approved ELOCTATE™ [Antihemophilic Factor (Recombinant), Fc Fusion Protein] for the […]

Video: Taking Control of Your Health

Many individuals with bleeding disorders are finding better health by being physically active.  Matthew Stinger is one such individual.  Matthew, who has hemophilia, has benefited from swimming & biking and one way he gives back to others within the bleeding disorders community is by participating in HFA’s annual Gears for Good bike ride.Learn about Matthew and […]